Fifth Third Bancorp (NASDAQ:FITB) announced that the Board of Governors of the Federal Reserve System (“the Federal Reserve”) did not object to Fifth Third’s proposed potential capital actions from April 1, 2015 through June 30, 2016 included in its capital plan submitted in January under the Comprehensive Capital Analysis and Review (“CCAR”) process. On Monday shares of Fifth Third Bancorp (NASDAQ:FITB) closed at $19.25. Company’s sales growth for last 5 years was -2.90% and EPS growth for next 5 years is recorded as 6.17%.
On March 12, it was reported that, Cisco Systems, Inc. (NASDAQ:CSCO) has confirmed an extension of its partnership with Microsoft through a blog post on the company’s Web site. The former rivals formed a new partnership last year through the Intercloud announcement and based on cloud and data centre solutions. Cisco Systems, Inc. (NASDAQ:CSCO) in last trading activity advanced 1.29% to close at $28.30. Company weekly performance is -3.61% while its quarterly performance stands at 5.56%. Cisco Systems, Inc. (NASDAQ:CSCO) is -6.63% away from its 52 week high.
Universal Health Services Inc. (NYSE:UHS)’s Chief Executive Officer Alan B. Miller, presented at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 11, 2015 at 9:00 AM Eastern Time. On last trading day Universal Health Services Inc. (NYSE:UHS) advanced 1.86% to close at $116.20. Its volatility for the week is 1.69% while volatility for the month is 2.27%. UHS’s sales growth for past 5 years was 9.20% and its EPS growth for past 5 years was 15.50%. Universal Health Services Inc. (NYSE:UHS) monthly performance is 11.74%.
Cooper Tire & Rubber Co. (NYSE:CTB) filed a motion asking a Delaware federal judge to throw out a class action lawsuit on behalf of its stockholders in relation to its failed buyout by Apollo Tyres, according to the Findlay Courier. The tiremaker argues the case has not merit. Cooper Tire & Rubber Co. (NYSE:CTB) has 1.40% insider ownership while its institutional ownership stands at 91.10%. In last trading activity company’s stock closed at $38.92.
Brean Capital reaffirmed their buy rating on shares of Recro Pharma Inc (NASDAQ:REPH) in a research note issued to investors on Tuesday. The firm currently has a $26.00 price target on the stock. On last trading day Recro Pharma, Inc. (NASDAQ:REPH) advanced 25.71% to close at $7.48. Its volatility for the week is 24.28% while volatility for the month is 9.88%. Recro Pharma, Inc. (NASDAQ:REPH) monthly performance is 130.44%.